<DOC>
	<DOC>NCT01430650</DOC>
	<brief_summary>The aim of this trial is compare two different endometrial priming protocols - women that receive oral estrogens - women that receive transdermal estrogens</brief_summary>
	<brief_title>Endometrial Priming for Embryo Transfer</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Permixon</mesh_term>
	<criteria>Women between 1850 years old with desire of children and needs of embryo transfer. Plasma prolactin less than 30. Uterine cavity that allow pregnancy, body mass index between 2030. And signed consent inform. History of estrogen dependent cancer, unknown origin vaginal bleeding. Ovarian cyst. Contraindications to be pregnant. Estrogen allergy.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Oral estrogens</keyword>
	<keyword>transdermal estrogens</keyword>
	<keyword>endometrial priming</keyword>
</DOC>